China and the U.S. Entity List
Foreign entities are often placed on the U.S. Entity List. But many of their subsidiaries and affiliates are not. Is that a problem?
Miniso’s Moment?
After a big NYSE debut, the Chinese retailer could face an uphill battle.
The PLA’s Unlikely Wingman
AVIC, China’s aerospace behemoth, has been known to steal U.S. trade secrets. But it's also been allowed to buy them. After the 2008 financial crisis,...
Evergrande’s Ever-Growing Debt Problem
A look into China's second largest real estate developer's ownership, assets, and debt.
The ZTE Conundrum
While Huawei's fate seems settled, the U.S. has offered a kind of lifeline to ZTE. Why?
Are Chinese Drones a National Security Threat or Required for the National Interest?
The U.S. government can't seem to decide.
Rich Gelfond on IMAX, Covid-19, and Standing on Your Own in China
The CEO of IMAX talks about why his China operation acts like a local company and how that mentality has helped them weather storms like...
Who is Hillhouse Capital?
We dissect one of the world’s most powerful private equity firms.
The Great Delisting?
Regulation of Chinese companies listed in the U.S. seems increasingly likely — but could it backfire?
China’s Best Shots
A look at the five Chinese companies furthest along in the search for a Covid-19 vaccine.
Beijing’s Big Ant Bet
How the Chinese government acquired an 8 percent stake in Ant Group.
L.A. Confidential
How a group of Chinese developers found a City Councilman, made over L.A.'s downtown, and caused the city's biggest corruption scandal in decades.